CIK 0001598599 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq, OTC · incorporated in I0 · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-21 | 6-K | 6-K | 2026-10-21 |
| 2026-10-20 | 6-K | 6-K | 2026-10-20 |
| 2026-09-17 | 6-K | 6-K | 2026-09-17 |
| 2026-09-17 | 6-K | 6-K | 2026-06-30 |
| 2026-09-17 | 6-K | 6-K | 2026-09-16 |
| 2026-09-10 | 6-K | 6-K | 2026-09-10 |
| 2026-09-02 | 6-K | 6-K | 2026-09-02 |
| 2026-08-19 | 6-K | 6-K | 2026-08-19 |
| 2026-08-14 | 6-K | 6-K | 2026-08-14 |
| 2026-08-10 | 6-K | 6-K | 2026-08-10 |
| 2026-07-23 | 6-K | 6-K | 2026-07-23 |
| 2026-07-21 | 6-K | 6-K | 2026-07-21 |
| 2026-06-22 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-22 | 6-K | 6-K | 2026-05-22 |
| 2026-05-19 | 6-K | 6-K | 2026-05-19 |
| 2026-05-13 | 6-K | 6-K | 2026-05-13 |
| 2026-05-12 | 6-K | 6-K | 2026-05-12 |
| 2026-05-06 | 6-K | 6-K | 2026-05-06 |
| 2026-04-23 | 6-K | 6-K | 2026-04-23 |
| 2026-04-17 | 6-K | 6-K | 2026-04-17 |
| 2026-04-13 | 6-K | 6-K | 2026-04-13 |
| 2026-04-13 | 6-K | 6-K | 2026-04-13 |
| 2026-04-10 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-04-08 | 6-K | 6-K | 2026-04-08 |
| 2026-04-03 | 6-K | 6-K | 2026-04-03 |
Forms on file (last 1,000): 6-K 277, 20-F 7, SCHEDULE 13G/A 5, EFFECT 4, CORRESP 4, UPLOAD 4, 424B5 3, SCHEDULE 13D/A 2. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=IPHA (0.002 USD), /gw/filings/filings?ticker=IPHA&form=8-K, /gw/filings/facts?ticker=IPHA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange